Answers are grounded in this paper and cite their sources.
This study found that, among patients who underwent PCI for AMI complicated by cardiogenic shock, overall use of MCS devices was constant, and a 2.5-fold increase in intravascular microaxial LVAD use was found along with a corresponding decrease in IABP use and a significant hospital-level variation in MCS device use. These trends were observed despite limited clinical trial evidence of improved outcomes associated with device use.
No takes yet. Share an insight, caveat, or question.
Dhruva et al. (2021) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: